INNOVATE Corp (VATE)
NYSE:VATE
Want to see VATE full AI Analyst Report?
VATE Stock Chart & Stats
$5.05
$0.04(0.71%)
At close: 4:00 PM EST
$5.05
$0.04(0.71%)
Day’s Range― - ―
52-Week Range$3.75 - $10.99
Previous CloseN/A
Volume9.40K
Average Volume (3M)26.90K
Market Cap
$134.13M
Enterprise Value$752.33M
Total Cash (Recent Filing)$112.10M
Total Debt (Recent Filing)$717.50M
Price to Earnings (P/E)―
Beta2.38
Next Earnings
May 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding13,645,127
10 Day Avg. Volume53,214
30 Day Avg. Volume26,900
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-0.26
Price to Sales (P/S)0.05
P/FCF Ratio0.50
Enterprise Value/Market Cap5.61
Enterprise Value/Revenue0.60
Enterprise Value/Gross Profit4.13
Enterprise Value/Ebitda13.63
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Backlog VisibilityA $1.6B+ adjusted backlog at DBM Global provides multi‑period revenue visibility for the Infrastructure arm, smoothing near‑term cyclicality and supporting predictable cash inflows. Durable backlog reduces revenue execution risk and underpins operating leverage as projects convert to billings.
Free Cash Flow ReboundMeaningful positive free cash flow in 2025 signals the business can generate internal liquidity to fund operations, service debt, and selectively invest. While historical inconsistency remains, sustained FCF would materially improve financial flexibility and enable deleveraging or strategic reinvestment over quarters.
Regulatory & Commercial ProgressEU CE Mark and complementary approvals expand MediBeacon's addressable market in clinical research and care. Regulatory clearances accelerate commercialization, clinical adoption, and reimbursement discussions, strengthening the life sciences segment's structural growth prospects and long‑term value capture.
Bears Say
High LeverageExtremely high leverage and a minimal equity cushion constrain strategic flexibility and elevate refinancing, covenant and interest‑coverage risk. In downturns, limited capital buffers increase the likelihood of distressed asset sales, restricted capital spending, and higher effective funding costs over multiple quarters.
Persistent LossesOngoing net losses and a negative EBITDA margin indicate the company has yet to convert revenue growth into sustainable profitability. This limits retained earnings accumulation, hampers internal capital formation, and forces reliance on external financing or asset distributions to fund operations long term.
Margin Pressure & Segment VolatilitySignificant margin compression at DBM and a weak Spectrum segment expose structural cost and demand challenges. Margin declines erode free cash flow sensitivity to revenue and amplify the impact of cyclical downturns, while Spectrum's ad dependence adds recurring volatility to consolidated results.
INNOVATE Corp News
VATE FAQ
What was INNOVATE Corp’s price range in the past 12 months?
INNOVATE Corp lowest stock price was $3.75 and its highest was $10.99 in the past 12 months.
What is INNOVATE Corp’s market cap?
INNOVATE Corp’s market cap is $134.13M.
When is INNOVATE Corp’s upcoming earnings report date?
INNOVATE Corp’s upcoming earnings report date is May 12, 2026 which is in 25 days.
How were INNOVATE Corp’s earnings last quarter?
INNOVATE Corp released its earnings results on Mar 26, 2026. The company reported -$0.585 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.585.
Is INNOVATE Corp overvalued?
According to Wall Street analysts INNOVATE Corp’s price is currently Overvalued.
Does INNOVATE Corp pay dividends?
INNOVATE Corp pays a Notavailable dividend of $38.9 which represents an annual dividend yield of N/A. See more information on INNOVATE Corp dividends here
What is INNOVATE Corp’s EPS estimate?
INNOVATE Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INNOVATE Corp have?
INNOVATE Corp has 13,645,127 shares outstanding.
What happened to INNOVATE Corp’s price movement after its last earnings report?
INNOVATE Corp reported an EPS of -$0.585 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.896%.
Which hedge fund is a major shareholder of INNOVATE Corp?
Currently, no hedge funds are holding shares in VATE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
INNOVATE Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
VATE Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 13.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.61%
12-Months-Change
Fundamentals
Return on Equity
27.42%
Trailing 12-Months
Asset Growth
6.62%
Trailing 12-Months
Company Description
INNOVATE Corp
INNOVATE Corp (VATE) is a forward-thinking technology company specializing in cutting-edge solutions across various sectors including artificial intelligence, renewable energy, and advanced manufacturing. The company focuses on developing innovative products and services that enhance efficiency and sustainability for businesses and consumers alike, leveraging its expertise in software development, hardware integration, and data analytics.
VATE Company Deck
VATE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic advancements in various segments, such as significant backlog increases and regulatory approvals. However, there were challenges such as margin compression, declines in Spectrum revenue, and increased indebtedness.View all VATE earnings summariesTechnical Analysis
SUNation Energy
―
Energy Services of America
―
Shimmick Corporation
―
SKK Holdings Limited
―
Ming Shing Group Holdings Limited
―
Ownership Overview
56.51% Insiders
3.14% Mutual Funds
8.38% Other Institutional Investors
30.21% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---